Company profile: Nano Diagnostics
1.1 - Company Overview
Company description
- Provider of hand-held point-of-care diagnostics, including the NanoDx System with nanowire biosensor technology for results in minutes; a TBI test offering quantitative assessment via key biomarkers for screening and monitoring mild brain injury; a COVID-19 antigen test from nasal, throat, or saliva samples; and data management tools with EHR integration and a web portal.
Products and services
- Data Management Tools: EHR-integrated data management components that integrate with electronic health records and include a web portal for managing users and devices
- NanoDx™ System: A hand-held, nanowire-based point-of-care platform that performs rapid biosensor diagnostic testing and delivers test results in minutes for screening and monitoring mild brain injury
- TBI test: A biomarker-based assay providing quantitative assessment of traumatic brain injury via measurement of key TBI biomarkers for screening and monitoring mild brain injury
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nano Diagnostics
Bio-AMD
HQ: United Kingdom
Website
- Description: Provider of biotechnology as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-AMD company profile →
Orgentec
HQ: Germany
Website
- Description: Provider of laboratory autoimmune diagnostic solutions, developing, producing and marketing test systems including more than 200 ELISA test systems, blot and immunofluorescence tests, and fully automated ELISA analyzers Alegria and Alegria 2 using SMC technology for in-vitro diagnostics. Applications include autoimmune and infectious diseases such as rheumatic, thrombosis, vasculitis, diabetes, and gastrointestinal disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orgentec company profile →
HealthFair
HQ: United States
Website
- Description: Provider of health and wellness services including awareness, education and preventive health tests via mobile health centers to help consumers improve and extend lives through early detection and prevention of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthFair company profile →
Euroclinic
HQ: Italy
Website
- Description: Provider of high-tech medical equipment, specializing in the production and distribution of professional and diagnostic chairs and units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euroclinic company profile →
Flagship Biosciences
HQ: United States
Website
- Description: Provider of AI-enabled tissue profiling via the cTA pathology platform, offering SPATIALPlex spatial biology, Flagship Data Science for per-cell analysis integrating spatial proteomic/genomic data, multiplex IHC/FISH/CISH assay development and validation, genomics sequencing and gene expression, flow cytometry for hematopoietic neoplasms and immunophenotyping, and AI-driven digital pathology/image analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flagship Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nano Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nano Diagnostics
2.2 - Growth funds investing in similar companies to Nano Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nano Diagnostics
4.2 - Public trading comparable groups for Nano Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →